Biological markers predictive of anticancer response to insulin-like growth factor-1 receptor kinase inhibitors

Details for Australian Patent Application No. 2008307634 (hide)

Owner OSI Pharmaceuticals, Inc.

Inventors Buck, Elizabeth A.

Agent Spruson & Ferguson

Pub. Number AU-A-2008307634

PCT Pub. Number WO2009/045361

Priority 60/997,445 03.10.07 US

Filing date 29 September 2008

Wipo publication date 9 April 2009

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

25 February 2010 PCT application entered the National Phase

  PCT publication WO2009/045361 Priority application(s): WO2009/045361

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008307636-Noninvasive fluid density and viscosity measurement

2008307633-Tumor suppression using human placental perfusate and human placentaderived intermediate natural killer cells